Loading clinical trials...
Loading clinical trials...
Few chemotherapeutic options exist for pancreatic cancer. Moreover, objective criteria are lacking for deciding which regimen is more beneficial for patient presenting with metastases at diagnosis. T...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Prof. Dr. med. Dres. h.c. Jan Schmidt, MME
NCT05825066 · Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, and more
NCT07282912 · Foregut Adenocarcinoma, Esophageal Adenocarcinoma, and more
NCT04485286 · Lung Cancer, Radiation Fibrosis, and more
NCT04605913 · Pancreas Cancer, Metastatic Pancreatic Cancer, and more
NCT06051695 · Solid Tumor, Adult, Colorectal Cancer, and more
Hirslanden Kliniks
Zurich, Canton of Zurich
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions